Illumina and FlowJo, LLC Partner to Develop and Co-Market a Software Solution for Single Cell Genomics
August 10 2016 - 6:30AM
Business Wire
Software for analysis and reporting of single
cell data will advance research into cell function, disease
progression, and therapeutic response
Illumina, Inc. (NASDAQ: ILMN) and FlowJo, LLC, today announced a
partnership to develop and co-market analysis software for single
cell next-generation sequencing (NGS) data. Under the agreement
FlowJo, LLC, the producer of FlowJo, market-leading software for
single cell analysis, will develop a new software application. It
will provide additional secondary and tertiary analysis and
visualization of datasets with an intuitive approach built on 19
years of experience working with cell biologists and immunologists
in single cell phenotyping. The application will seamlessly
integrate with Illumina’s Single Cell RNA BaseSpace app, and
provide a solution accelerating discovery.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20160810005216/en/
“We are excited to partner with Illumina on this project to
bring new tools for analyzing and visualizing NGS data to cell
biology,” said Michael Stadnisky, PhD, CEO of FlowJo, LLC. “The new
offering will enhance the power of single cell biology research by
empowering robust exploration of data from Illumina next-generation
sequencing runs.”
“FlowJo, LLC is recognized for delivering reliable, high-quality
and easy-to-use software solutions that allow cell biologists to
study phenotype in individual cells by flow cytometry,” said Rob
Brainin, Vice President and General Manager, Applied Genomics at
Illumina. “We look forward to enabling our customers to bring these
trusted FlowJo analytical capabilities to their next-generation
sequencing data.”
The software will complement the end-to-end commercial solution
for high-throughput sequencing of single cells that Illumina
announced it is co-developing in partnership with Bio-Rad
Laboratories, Inc. (NYSE: BIO) (NYSE: BIOb).
The companies expect the software to be available in Q1
2017.
About Illumina
Illumina is improving human health by unlocking the power
of the genome. Our focus on innovation has established us as the
global leader in DNA sequencing and array-based technologies,
serving customers in the research, clinical and applied markets.
Our products are used for applications in the life sciences,
oncology, reproductive health, agriculture, and other emerging
segments. To learn more, visit www.illumina.com and
follow @illumina.
About FlowJo, LLC
FlowJo, LLC is a privately owned life sciences software company
in Ashland, Oregon. Based on technology developed at Stanford, the
company was founded in 1997 and provides the leading analysis
platform for single cell flow and mass cytometry analysis. Their
software innovations enable collaboration, discovery,
high-throughput analysis, and data leadership in flow and mass
cytometry. For more information, see www.FlowJo.com.
Illumina Forward-Looking Statements
This release contains forward-looking statements that involve
risks and uncertainties, such as Illumina’s expectations regarding
the launch of any products. Important factors that could cause
actual results to differ materially from those in forward-looking
statements include the application of generally accepted accounting
principles, which are highly complex and involve many subjective
assumptions, estimates, and judgments, and the other factors
detailed in Illumina’s filings with the Securities and Exchange
Commission, including its most recent filings on Forms 10-K and
10-Q, or in information disclosed in public conference calls, the
date and time of which are released beforehand. Illumina assumes no
obligation to update any forward-looking statements after the date
of this release.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160810005216/en/
Illumina, Inc.Investors:Rebecca
Chambers858-255-5243ir@illumina.comorMedia:Gwen
Gordon858-882-6822pr@illumina.comorFlowJo, LLCMedia:Caitlin
Farquhar800-366-6045caitlinf@flowjo.com
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Apr 2023 to Apr 2024